We are delighted to welcome you to the second edition of the ESMO Targeted Anticancer Therapies Asia Congress, taking place from 12 to 14 June 2026 in Hong Kong SAR, China. Building on the success of our inaugural event, this congress continues to serve as a key platform in the Asia-Pacific region for showcasing the latest advances in early-phase drug development and precision oncology.
Designed for researchers, clinicians, and industry professionals at the forefront of innovation, ESMO TAT Asia 2026 offers an exceptional opportunity to explore cutting-edge science, foster cross-disciplinary collaboration, and accelerate the translation of novel therapies into clinical practice. Join us as we bring together global experts and regional leaders to shape the future of targeted anticancer treatment.